Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

15.82 -3.84 (-19.53%)
Official Closing Price Updated: 4:10 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,702,259
Open 16.78
Bid (Size) 15.91 (2)
Ask (Size) 15.98 (2)
Prev. Close 19.66
Today's Range 14.69 - 17.10
52wk Range 15.79 - 55.70
Shares Outstanding 65,401,228
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Is Biohaven Stock Falling On Thursday?
Biohaven secures $250 million from Oberland Capital, with total cash reaching $518 million to support troriluzole launch and operations. 
Via Benzinga
Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug
The company hadn't expected an advisory committee meeting, nor a three-month pushback for its rare-disease drug review. 
Via Investor's Business Daily
Exposures Product Safety

Performance

YTD
-57.6%
-57.6%
1 Month
-14.5%
-14.5%
3 Month
-62.4%
-62.4%
6 Month
-67.7%
-67.7%
1 Year
-57.5%
-57.5%

More News

Read More
Red Cat Holdings, Alibaba, DXC Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Why BioHaven Stock Is Soaring Today
Via The Motley Fool
Topics Stocks
Exposures Product Safety US Equities
Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland
Via Benzinga
Why Biohaven Stock Triumphed on Tuesday
Via The Motley Fool
What's Going On With Merus Stock Monday?
Via Benzinga
Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why Biohaven Stock Plummeted by More Than 15% Today
Via The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
From Pomerantz LLP
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
From Pomerantz LLP
Via GlobeNewswire
BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
From Pomerantz LLP
Via GlobeNewswire
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
Via The Motley Fool
Topics Bankruptcy Economy World Trade
Exposures Economy Financial Legal
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd - BHVN
From Pomerantz LLP
Via GlobeNewswire
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
From Avalo Therapeutics
Via GlobeNewswire
Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
Via Investor's Business Daily
Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy
Via Benzinga
Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?
Via Benzinga
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
Via Investor's Business Daily
Exposures Product Safety
Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory

Frequently Asked Questions

Is Biohaven Ltd. Common Shares publicly traded?
Yes, Biohaven Ltd. Common Shares is publicly traded.
What exchange does Biohaven Ltd. Common Shares trade on?
Biohaven Ltd. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Biohaven Ltd. Common Shares?
The ticker symbol for Biohaven Ltd. Common Shares is BHVN on the New York Stock Exchange
What is the current price of Biohaven Ltd. Common Shares?
The current price of Biohaven Ltd. Common Shares is 15.82
When was Biohaven Ltd. Common Shares last traded?
The last trade of Biohaven Ltd. Common Shares was at 05/15/25 04:10 PM ET
What is the market capitalization of Biohaven Ltd. Common Shares?
The market capitalization of Biohaven Ltd. Common Shares is 1.03B
How many shares of Biohaven Ltd. Common Shares are outstanding?
Biohaven Ltd. Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.